These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 5303720)

  • 21. Studies on the response of patients with classic hemophilia to transfusion with concentrates of antihemophilic factor. A difference in the half-life of antihemophilic factor as measured by procoagulant and immunologic techniques.
    Bennett B; Ratnoff OD
    J Clin Invest; 1972 Oct; 51(10):2593-6. PubMed ID: 4626847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Classic hemophilia A in a female.
    Joist JH; Bouhasin JD; Roodman S
    Acta Haematol; 1977; 58(2):94-102. PubMed ID: 409025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Molecular defect in hemophilia and von Willebrand's disease (author's transl)].
    Fukui H
    Rinsho Byori; 1976 Apr; 24(4):274-8. PubMed ID: 1084430
    [No Abstract]   [Full Text] [Related]  

  • 24. Antigen-biological-activity ratio for factor VIII.
    Hougie C; Sargeant R
    Lancet; 1973 Mar; 1(7803):616-7. PubMed ID: 4120690
    [No Abstract]   [Full Text] [Related]  

  • 25. Molecular immunology of factor VIII.
    Zimmerman TS; Edgington TS
    Annu Rev Med; 1974; 25():303-14. PubMed ID: 4132887
    [No Abstract]   [Full Text] [Related]  

  • 26. Re-evaluation of plasmas from patients previously diagnosed as having von Willebrand's disease with the factor VIII-related antigen and ristocetin cofactor assay.
    Ness PM; Hymas PG; Perkins HA
    Am J Clin Pathol; 1979 Jan; 71(1):26-30. PubMed ID: 311154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factor VIII-related antigen in canine hemophilia and Von Willebrand's disease: Variation when measured with different agaroses.
    Benson RE; Bouma BN; Dodds WJ
    Thromb Res; 1975 Sep; 7(3):383-9. PubMed ID: 1081282
    [No Abstract]   [Full Text] [Related]  

  • 28. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The factor VIII complex: structure and function.
    Hoyer LW
    Blood; 1981 Jul; 58(1):1-13. PubMed ID: 6165414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunologic evidence that the antihemophilic factor (factor VIII)-like material in hemophilic plasma possesses a nonfunctional low molecular weight subcomponent.
    Poon MC; Ratnoff OD
    Blood; 1977 Sep; 50(3):367-76. PubMed ID: 301759
    [No Abstract]   [Full Text] [Related]  

  • 31. Occurrence of two hemorrhagic disorders with antihemophilic factor (AHF) deficiency in the same family: classical hemophilia and von willebrand's disease.
    GEIGER MT; RATH CE
    J Lab Clin Med; 1963 Mar; 61():424-36. PubMed ID: 13947010
    [No Abstract]   [Full Text] [Related]  

  • 32. Blood coagulation factor VIII (antihemophilic factor): with comments on von Willebrand's disease and Christmas disease.
    Barrow EM; Graham JB
    Physiol Rev; 1974 Jan; 54(1):23-74. PubMed ID: 4594032
    [No Abstract]   [Full Text] [Related]  

  • 33. Proceedings: Current knowledge of the AHF-like antigen.
    Meyer D
    Thromb Diath Haemorrh; 1975 Nov; 34(2):604-5. PubMed ID: 1081751
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antihemophilic globulin (AHG)-(factor VIII level)--how to read its figures].
    Kagami M
    Nihon Rinsho; 1971 Jan; 29():Suppl:584-91. PubMed ID: 4928290
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on the nature of antihemophilic factor (factor VIII). Further evidence relating the AHF-like antigens in normal and hemophilic plasmas.
    Bennett B; Forman WB; Ratnoff OD
    J Clin Invest; 1973 Sep; 52(9):2191-7. PubMed ID: 4199413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of the carrier state for classic hemophilia using an enzyme-linked immunosorbent assay (ELISA).
    Fishman DJ; Jones PK; Menitove JE; Ratnoff OD; Everson B
    Blood; 1982 Jun; 59(6):1163-8. PubMed ID: 6805530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship of the properties of antihemophilic factor (factor VIII) that support ristocetin-induced platelet agglutination (factor VIIIR:RC) and platelet retention by glass beads as demonstrated by a monoclonal antibody.
    Ogata K; Saito H; Ratnoff OD
    Blood; 1983 Jan; 61(1):27-35. PubMed ID: 6401215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Enzyme immunoassay of factor VIII-related antigen with observation in patients with von Willebrand's disease and hemophilia A (author's transl)].
    Okuda T; Masuyama H; Tanigawa T; Narihiro N; Fujimura Y; Takase T; Mikami S; Yoshioka A; Fukui H
    Rinsho Ketsueki; 1980 Jul; 21(7):946-52. PubMed ID: 6775115
    [No Abstract]   [Full Text] [Related]  

  • 39. A circulating anticoagulant selectively active against human antihemophilic factor (autoimmune hemophilia).
    SPAET TH; KINSELL BG
    Stanford Med Bull; 1954 Nov; 12(4):246-56. PubMed ID: 13225986
    [No Abstract]   [Full Text] [Related]  

  • 40. [Symposium on the blood coagulation and fibrinolysin. (6) Immunological studies on hemophilia A, carriers of hemophilia A and von Willebrand's disease (author's transl)].
    Kamiya T; Ishiguro J; Koie K; Saito H
    Nihon Naika Gakkai Zasshi; 1975 Oct; 64(10):1121-6. PubMed ID: 1081560
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.